
As regulatory authorities crack down on data integrity violations, bio/pharma companies must ensure adequate data governance programs are in place.
Thu Truong, JD, is senior associate of Science and Technology at Lachman Consultants.

As regulatory authorities crack down on data integrity violations, bio/pharma companies must ensure adequate data governance programs are in place.

Data governance is necessary for compliance with current regulatory expectations for data integrity in pharmaceutical R&D and manufacturing organizations.

Published: November 2nd 2017 | Updated:

Published: December 6th 2017 | Updated: